Back to Top Skip to main content Skip to sub-navigation

You also may be interested in...

Suicide Prevention Mooney

Congressional Testimony
4/6/2022

RICHARD L. MOONEY, M.D., M.P.H., ACTING DEPUTY ASSISTANT SECRETARY OF DEFENSE, HEALTH SERVICE POLICY & OVERSIGHT HEALTH AFFAIRS [testified] BEFORE THE SENATE ARMED SERVICES SUBCOMMITTEE ON PERSONNEL

Lieutenant General Ronald Place, Director, Defense Health Agency [testified] before House Armed Services Committee, Military Personnel Subcommittee

Congressional Testimony
3/30/2022

Prepared Statement of Lieutenant General Ronald Place Director Regarding Patient Safety and Quality of Care Before the House Armed Services Committee Military Personnel Subcommittee

Dr. David Smith, Performing the Duties of the Assistant Secretary of Defense (Health Affairs) And LTG Ronald Place, Director, Defense Health Agency [testified] before the Senate Appropriations Committee, Defense Subcommittee

Congressional Testimony
3/29/2022

Prepared Statement of Richard L. Mooney M.D. M.P.H. Acting Deputy Assistant Secretary of Defense, Health Service Policy & Oversight Health Affairs

Congressional Testimony
3/2/2022

Prepared Statement of Dr. Terry Adirim, MD, MPH, MBA Acting Assistant Secretary of Defense (Health Affairs) and Lieutenant General (Dr) Ronald Place Director, Defense Health Agency Regarding The Military Health System

Congressional Testimony
6/15/2021

Prepared Statement of Dr. Terry Adirim, MD, MPH, MBA Acting Assistant Secretary of Defense (Health Affairs) and Lieutenant General (Dr) Ronald Place Director, Defense Health Agency Regarding The Military Health System Before the House Appropriation Committee Defense Subcommittee

Dr. Terry Adirim, MD, MPH, MBA Acting Assistant Secretary of Defense (Health Affairs) Regarding the Military Health System [Testified] Before the Senate Appropriations Committee Defense Subcommittee

Congressional Testimony
4/20/2021

Prepared Statement of Karin A. Orvis PH.D. Director Defense Suicide Prevention Office and Chad Bradford. Capt. MC, USN Director, Mental Health Policy & Oversight Health Affairs

Congressional Testimony
3/24/2021

Terry M. Rauch, Ph.D., M.P.H., M.B.A. Director, Research and Development Policy & Oversight Health Readiness Policy and Oversight Regarding Remediation and Impact of PFAS on Servicemembers [Testified] Before the House Committee on Appropriations Subcommittee on Military Construction, Veterans Affairs, and Related Agencies

Congressional Testimony
2/24/2021

Recommended Content:

Perfluoroalkyl and Polyfluoroalkyl Substances

DoD Instruction 6055.12: Hearing Conservation Program

Congressional Testimony
2/19/2021

In accordance with the authority in DoD Directive (DoDD) 5134.01 and the April 10, 2019 Deputy Secretary of Defense Memorandum, this issuance: •Implements policy, assigns responsibilities, and provides procedures for administering an HCP to prevent hearing loss resulting from occupational and operational illness and injury. •Establishes the DoD Hearing Conservation Working Group (HCWG). •Issues requirements for the integration of noise control into the life cycle of DoD systems and equipment. APPENDIX B

Recommended Content:

Hearing and Balance Injuries

David J. Smith, M.D. Deputy Assistant Secretary of Defense for Health Readiness and Policy Oversight Health Concerns of Veterans and Servicemembers Deployed to Karshi-Khanabad Between 2001 and 2005 [Testified] Before the House Committee on Oversight and Reform Subcommittee

Congressional Testimony
11/18/2020

Prepared Statement for the Record Regarding Toxic Exposures: Examining Airborne Hazards in the Southwest Asia Theater of Military Operations [Testified] Before the House Veterans Affairs Committee Subcommittee on Disability and Memorial Affairs

Congressional Testimony
9/23/2020

Inclusion of Women and Minorities in the Congressionally Directed Medical Research Program

Congressional Testimony
9/16/2020

S. 2474, SAC-D Report for FY 2020, 116-103, Pg. 239-240

The Honorable TERRY M. RAUCH, Ph.D., M.P.H., M.B.A. ACTING DEPUTY ASSISTANT SECRETARY OF DEFENSE HEALTH READINESS POLICY AND OVERSIGHT Regarding Per-and Polyfluoroalkyl Substances (PFAS) Update [Testified] Before the House Armed Services Committee Readiness Subcommittee

Congressional Testimony
9/15/2020

Recommended Content:

Perfluoroalkyl and Polyfluoroalkyl Substances

TRICARE Comprehensive Autism Care Demonstration Program

Congressional Testimony
9/14/2020

S. 2943, SASC Report for FY 2017, 114-255, Pg. 205

Unhealthy Alcohol Use Report

Congressional Testimony
9/14/2020

H.R. 2500, HASC Report for FY 2020, 116-120, Pg. 167-168

<< < 1 2 3 4 5  ... > >> 
Showing results 1 - 15 Page 1 of 20

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.